#1 Clinical Trials Search in Europe

Candesartan

This article examines the use of Candesartan, an angiotensin II receptor blocker, in various clinical trials. These studies investigate Candesartan’s effectiveness in treating conditions like hypertension, diabetes-related complications, and cardiovascular issues. The trials provide valuable insights into the drug’s safety profile and its potential benefits for different patient populations.

Table of Contents

What is Candesartan?

Candesartan, also known by its full name candesartan cilexetil, is a medication primarily used to treat high blood pressure (hypertension) and heart-related conditions. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs)[1]. Candesartan is marketed under various brand names, including Atacand, Blopress, and others[2][3].

What Conditions Does Candesartan Treat?

Candesartan is used to treat several conditions, including:

  • Hypertension (High Blood Pressure): This is the primary use of candesartan in adults and children[4].
  • Heart Failure: It can help improve heart function in patients with heart failure[5].
  • Diabetic Nephropathy: Candesartan may help protect the kidneys in patients with type 2 diabetes and high blood pressure[4].
  • Diabetic Retinopathy: Studies have investigated its potential in preventing or slowing the progression of eye problems in diabetic patients[6][7].

How Does Candesartan Work?

Candesartan works by blocking the action of a hormone called angiotensin II. This hormone normally causes blood vessels to narrow, which can increase blood pressure. By blocking this hormone, candesartan helps blood vessels relax and widen, lowering blood pressure and reducing strain on the heart[1].

Dosage and Administration

Candesartan is typically taken orally as a tablet once daily. The dosage can vary depending on the condition being treated and the patient’s response to the medication:

  • For hypertension in adults, the usual starting dose is 4 to 8 mg once daily, which can be increased up to 32 mg if needed[8].
  • For children with hypertension, the dose is usually based on weight[2].
  • Patients with kidney problems may start with a lower dose of 2 mg daily[8].

It’s important to take candesartan exactly as prescribed by your doctor. The medication is usually taken in the morning, with or without food[1].

Effectiveness of Candesartan

Clinical trials have shown candesartan to be effective in treating hypertension and other conditions:

  • It can significantly lower both systolic and diastolic blood pressure in patients with hypertension[9].
  • In patients with heart failure, candesartan may reduce the risk of cardiovascular events[5].
  • Studies have investigated its potential in slowing the progression of diabetic retinopathy, although more research is needed in this area[6][7].

Potential Side Effects

Like all medications, candesartan can cause side effects, although not everyone experiences them. Common side effects may include:

  • Dizziness
  • Headache
  • Back pain
  • Respiratory infections

More serious side effects, though rare, can include severe low blood pressure, kidney problems, or high potassium levels in the blood. It’s important to discuss any side effects with your healthcare provider[9].

Special Considerations

There are some important considerations when taking candesartan:

  • Pregnancy: Candesartan can harm an unborn baby and should not be used during pregnancy[1].
  • Breastfeeding: It’s not known if candesartan passes into breast milk. Discuss with your doctor if you’re breastfeeding.
  • Kidney and Liver Function: Your doctor may need to adjust your dose if you have kidney or liver problems[8].
  • Drug Interactions: Candesartan can interact with other medications, including some over-the-counter drugs. Always inform your healthcare provider about all medications you’re taking.

Remember, this information is not a substitute for medical advice. Always consult with your healthcare provider for personalized information about your treatment with candesartan.

Aspect Details
Drug Name Candesartan (also known as Candesartan Cilexetil, Atacand, Blopress)
Drug Class Angiotensin II receptor blocker (ARB)
Main Indications Hypertension, diabetic retinopathy, cardiovascular protection
Dosage Forms Tablets (various strengths), oral liquid (for pediatric use)
Dosage Range 2 mg to 32 mg daily, depending on indication and patient factors
Key Study Populations Adults with hypertension, diabetic patients, patients with coronary artery disease, children with hypertension
Primary Outcomes Blood pressure reduction, progression of diabetic retinopathy, cardiovascular events, urinary albumin excretion
Safety Considerations Monitoring for adverse events, special dosing for renal impairment
Notable Trial Designs Bioequivalence studies, long-term safety and efficacy studies, comparison with placebo or other treatments

FAQ

  • What is Candesartan used for in clinical trials? Candesartan is used in clinical trials to treat various conditions, including hypertension, diabetic retinopathy, and cardiovascular issues in patients with coronary artery disease. It's also studied for its potential renoprotective effects in patients with non-diabetic nephropathy.
  • How is Candesartan administered in these trials? Candesartan is typically administered orally in tablet form. The dosage varies depending on the study and patient condition, ranging from 2 mg to 32 mg daily. Some trials use a liquid formulation for pediatric patients.
  • What are some of the primary outcomes measured in Candesartan trials? Primary outcomes often include changes in blood pressure, progression or regression of diabetic retinopathy, incidence of cardiovascular events, and changes in urinary albumin excretion rate. Some trials also measure bioequivalence parameters.
  • Are there any special considerations for certain patient groups? Yes, some trials focus on specific patient groups such as children, patients with renal impairment, or those with metabolic syndrome. Dosing may be adjusted for these groups, and additional safety monitoring may be implemented.
  • What are some of the potential side effects of Candesartan observed in clinical trials? While specific side effects aren't detailed in the provided trial summaries, clinical trials typically monitor for adverse events. Common side effects of Candesartan may include dizziness, headache, and upper respiratory tract infections. Serious side effects are rare but can include kidney problems or high potassium levels.

Ongoing Clinical Trials on Candesartan

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Denmark Norway

  • A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Denmark Norway

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Spain

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    1 1
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy Portugal +1

Glossary

  • Angiotensin II receptor blocker (ARB): A type of medication that blocks the action of angiotensin II, a hormone that narrows blood vessels, thereby helping to lower blood pressure.
  • Bioequivalence: The property of two drug products having the same biological effect in the body, typically measured by comparing their pharmacokinetic parameters.
  • Diabetic retinopathy: A complication of diabetes that affects the eyes, causing damage to the blood vessels in the retina.
  • Early Treatment Diabetic Retinopathy Study (ETDRS) Severity Scale: A standardized scale used to assess the severity of diabetic retinopathy, consisting of 11 steps.
  • Hypertension: A medical condition characterized by persistently elevated blood pressure in the arteries.
  • Metabolic syndrome: A cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes.
  • Microalbuminuria: The presence of small amounts of albumin in the urine, often an early sign of kidney disease.
  • Nephropathy: Damage or disease of the kidney, which can lead to kidney failure.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Renoprotective: Having a protective effect on the kidneys, helping to prevent or slow down kidney damage.

References

  1. https://clinicaltrials.gov/study/NCT04012307
  2. https://clinicaltrials.gov/study/NCT00244621
  3. https://clinicaltrials.gov/study/NCT02211638
  4. https://clinicaltrials.gov/study/NCT00573430
  5. https://clinicaltrials.gov/study/NCT00139386
  6. https://clinicaltrials.gov/study/NCT00252694
  7. https://clinicaltrials.gov/study/NCT00252720
  8. https://clinicaltrials.gov/study/NCT02166697
  9. https://clinicaltrials.gov/study/NCT01788358